Cytosar-U

Active Ingredient(s): Cytarabine, ARA-C
FDA Approved: * December 30, 1998
Pharm Company: * SICOR PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cytosar-U Overview

Cytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and non-Hodgkin's lymphoma.[1] It is given by injection into a vein, under the skin, or into the cerebrospinal fluid.[1] There is a liposomal formulation for which there is tentative evidence of better outcomes in lymphoma involving the meninges.[1] ...

Read more Cytosar-U Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cytarabine

Recent Cytosar-U Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cytarabine, ARA-C
  • Injection: 100mg, 100mg/ml, 100mg/vial, 1g, 1gm/vial, 20mg/ml, 2g, 2gm/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Cytarabine, ARA-C or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 April 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA